Iambic Therapeutics

About:

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Website: https://www.iambic.ai

Twitter/X: iambic_ai

Top Investors: NVIDIA, Sequoia Capital, Alumni Ventures, Nexus Venture Partners, OrbiMed

Description:

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinic with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai.

Total Funding Amount:

$203M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2019-01-01

Contact Email:

contact(AT)iambic.ai

Founders:

Fred Manby, Sarah Trice, Thomas Miller

Number of Employees:

51-100

Last Funding Date:

2024-04-24

IPO Status:

Private

© 2024 MyAiNote.com